IP Library Granted Patent US 8,269,040
Granted Patent B2
US 8,269,040 · App. 10/720,134 · Granted Sep 18, 2012

Derivatives of venlafaxine and methods of preparing and using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,269,040
App. No.
10/720,134
Granted
Sep 18, 2012
Kind
B2
Abstract

Methods of preparing, and compositions comprising, derivatives of venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders.

Claims (2)

1. A compound which is O-desmethylvenlafaxine succinate, wherein the compound is a hydrate of O-desmethylvenlafaxine succinate.

2. The compound of claim 1 which is O-desmethylvenlafaxine succinate monohydrate.

Assignments (3)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 27, 2023
From: WYETH LLC
To: WYETH LLC
Reel/Frame 063165/0455 →
ASSIGNEE ADDRESS CORRECTION Recorded Oct 12, 2016
From: SEPRACOR INC.
To: WYETH LLC
Reel/Frame 040332/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2010
From: SEPRACOR INC.
To: WYETH LLC
Reel/Frame 024681/0971 →